JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

News

Home |
News

All Categories

19 May

ImmunoPrecise Increases Financing to $2.592 Million

Closing of the offering is subject to acceptance of the TSX Venture Exchange.
...
READ MORE
19 May

ImmunoPrecise Closes Oversubscribed Debenture Financing

The offering will be used to expand operations and sales in the United States, Canada and Europe and working capital purposes.
...
READ MORE
06 May

ImmunoPrecise Antibodies Increases Discovery Capabilities to Help Pinpoint Lead Drug Candidates with Addition of Octet HTX.

The octet HTX increases Immunoprecise's analytical throughput.
...
READ MORE
24 Apr

ImmunoPrecise Updates on State and Federal Funding.

This grant was the first application of many to be submitted by IPA over the next several months.
...
READ MORE
17 Apr

ImmunoPrecise Provides Updates on B Cell Select™ and Deep Display™ Programs for SARS-CoV-2 Antibody Discovery

IPA anticipates that it can accelerate anti-SARS-CoV-2 human antibody discovery.
...
READ MORE
15 Apr

ImmunoPrecise Participates in Public Consensus Statement, from the WHO, on Collaboration for Developing a COVID-19 Vaccine

IPA to provide an update on its participation to fight against coronavirus.
...
READ MORE